{"id":77038,"date":"2026-11-11T20:13:23","date_gmt":"2026-11-11T20:13:23","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=77038"},"modified":"2026-11-11T20:40:09","modified_gmt":"2026-11-11T20:40:09","slug":"american-analyst-updates-nov-11th-2026","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-11th-2026\/","title":{"rendered":"American Analyst Updates: Nov 11th, 2026"},"content":{"rendered":"

Analyst Ratings (USA)<\/strong><\/a><\/h2>\n

American analyst sentiment on November 11th remains mixed and increasingly cautious, with notable downgrades across artificial intelligence, semiconductors, software, financial services and energy highlighting concerns about elevated valuations, slowing earnings momentum and profitability. NVIDIA’s downgrade and substantial price-target reductions for CoreWeave suggest growing scrutiny of AI infrastructure investment and its long-term returns. However, upgrades for Apple and select industrial, healthcare and financial companies, alongside positive new coverage of semiconductor equipment and automation businesses, demonstrate continued confidence in structural growth opportunities.<\/p>\n

Updates (315)<\/strong><\/h3>\n

908 Devices (MASS)<\/strong> \u2014 Stifel Nicolaus maintains its Buy rating and raises its price target to $14.00 from $12.00.<\/p>\n

Acrivon Therapeutics (ACRV)<\/strong> \u2014 Jefferies Financial Group maintains its Buy rating.<\/p>\n

Adobe (ADBE)<\/strong> \u2014 Royal Bank Of Canada maintains its Outperform rating with a price target of $315.00.<\/p>\n

Akamai Technologies (AKAM)<\/strong> \u2014 Evercore ISI downgrades from Outperform to In-line with a price target of $90.<\/p>\n

Alamo Group (ALG)<\/strong> \u2014 DA Davidson maintains its Neutral rating and lowers its price target to $161.00 from $188.00.<\/p>\n

Alliance Laundry (ALH)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Overweight rating and lowers its price target to $31.00 from $32.00.<\/p>\n

Alliance Laundry (ALH)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and raises its price target to $29.00 from $28.00.<\/p>\n

Alliance Laundry (ALH)<\/strong> \u2014 Robert W. Baird maintains its Outperform rating and lowers its price target to $30.00 from $34.00.<\/p>\n

Alpha Tau Medical (DRTS)<\/strong> \u2014 Piper Sandler upgrades from Neutral to Overweight and raises its price target to $22.00 from $8.00.<\/p>\n

Alto Neuroscience (ANRO)<\/strong> \u2014 BTIG Research maintains its Buy rating with a price target of $37.00.<\/p>\n

Ambiq Micro (AMBQ)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating and lowers its price target to $65.00 from $85.00.<\/p>\n

Ambiq Micro (AMBQ)<\/strong> \u2014 Stifel Nicolaus maintains its Buy rating and lowers its price target to $70.00 from $85.00.<\/p>\n

Ameresco (AMRC)<\/strong> \u2014 Canaccord Genuity Group maintains its Buy rating and lowers its price target to $61.00 from $62.00.<\/p>\n

Ameresco (AMRC)<\/strong> \u2014 Stifel Nicolaus maintains its Buy rating and lowers its price target to $37.00 from $38.00.<\/p>\n

American Axle & Manufacturing (DCH)<\/strong> \u2014 Barclays maintains its Equal Weight rating and lowers its price target to $6.00 from $8.00.<\/p>\n

American Integrity Insurance Group (AII)<\/strong> \u2014 Citizens Jmp maintains its Market Outperform rating and raises its price target to $32.00 from $29.00.<\/p>\n

American Public Education (APEI)<\/strong> \u2014 Truist Financial maintains its Hold rating and lowers its price target to $41.00 from $55.00.<\/p>\n

American Water Works (AWK)<\/strong> \u2014 Argus maintains its Buy rating and raises its price target to $165.00 from $155.00.<\/p>\n

Apple (AAPL)<\/strong> \u2014 China Renaissance upgrades from Hold to Buy with a price target of $425.00.<\/p>\n

Archer Aviation (ACHR)<\/strong> \u2014 Canaccord Genuity Group maintains its Buy rating and lowers its price target to $9.50 from $12.00.<\/p>\n

Ardent Health (ARDT)<\/strong> \u2014 Mizuho sets a price target of $21.00.<\/p>\n

Astronics (ATRO)<\/strong> \u2014 TD Cowen maintains its Buy rating and lowers its price target to $80.00 from $90.00.<\/p>\n

Atlas Energy Solutions (AESI)<\/strong> \u2014 Barclays maintains its Equal Weight rating and lowers its price target to $7.00 from $13.00.<\/p>\n

Atlas Energy Solutions (AESI)<\/strong> \u2014 Citigroup maintains its Buy rating and lowers its price target to $16.00 from $17.00.<\/p>\n

Autolus Therapeutics (AUTL)<\/strong> \u2014 HC Wainwright maintains its Buy rating.<\/p>\n

Autolus Therapeutics (AUTL)<\/strong> \u2014 UBS Group maintains its Buy rating.<\/p>\n

Aviat Networks (AVNW)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and lowers its price target to $32.00 from $33.00.<\/p>\n

Bain Capital Specialty Finance (BCSF)<\/strong> \u2014 Noble Financial maintains its Neutral rating.<\/p>\n

Bain Capital Specialty Finance (BCSF)<\/strong> \u2014 Wells Fargo & Company maintains its Equal Weight rating and lowers its price target to $11.00 from $12.00.<\/p>\n

Bandwidth (BAND)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating.<\/p>\n

Bank of America (BAC)<\/strong> \u2014 UBS Group maintains its Buy rating with a price target of $62.00.<\/p>\n

Bausch Health Cos (BHC)<\/strong> \u2014 Barclays maintains its Equal Weight rating and raises its price target to $9.00 from $7.00.<\/p>\n

Beachbody (BODI)<\/strong> \u2014 Canaccord Genuity Group maintains its Buy rating and lowers its price target to $12.00 from $16.00.<\/p>\n

Beam Therapeutics (BEAM)<\/strong> \u2014 Wedbush maintains its Outperform rating and raises its price target to $33.00 from $30.00.<\/p>\n

Belden (BDC)<\/strong> \u2014 Jefferies Financial Group initiates coverage with a Hold rating with a price target of $114.00.<\/p>\n

Bicara Therapeutics (BCAX)<\/strong> \u2014 HC Wainwright maintains its Buy rating and lowers its price target to $36.00 from $42.00.<\/p>\n

BILL (BILL)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and raises its price target to $64.00 from $60.00.<\/p>\n

BILL (BILL)<\/strong> \u2014 UBS Group resumes coverage with a Buy rating and raises its price target to $64.00 from $60.00.<\/p>\n

Bitdeer Technologies Group (BTDR)<\/strong> \u2014 Barclays maintains its Overweight rating and lowers its price target to $14.00 from $17.00.<\/p>\n

Bitdeer Technologies Group (BTDR)<\/strong> \u2014 HC Wainwright maintains its Buy rating.<\/p>\n

Bitdeer Technologies Group (BTDR)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating and lowers its price target to $18.00 from $20.00.<\/p>\n

BJ’s Wholesale Club (BJ)<\/strong> \u2014 Bank of America maintains its Neutral rating.<\/p>\n

Black Rock Coffee Bar (BRCB)<\/strong> \u2014 DA Davidson maintains its Buy rating and raises its price target to $13.00 from $10.00.<\/p>\n

Black Rock Coffee Bar (BRCB)<\/strong> \u2014 Robert W. Baird maintains its Neutral rating and raises its price target to $10.00 from $8.00.<\/p>\n

Block (XYZ)<\/strong> \u2014 Sanford C. Bernstein maintains its Outperform rating and raises its price target to $110.00 from $95.00.<\/p>\n

Block (XYZ)<\/strong> \u2014 Truist Financial maintains its Buy rating and raises its price target to $95.00 from $89.00.<\/p>\n

Boeing (BA)<\/strong> \u2014 Susquehanna maintains its Positive rating.<\/p>\n

BridgeBio Oncology Therapeutics (BBOT)<\/strong> \u2014 Wedbush maintains its Outperform rating with a price target of $9.00.<\/p>\n

BrightView (BV)<\/strong> \u2014 Robert W. Baird maintains its Outperform rating and lowers its price target to $12.00 from $14.00.<\/p>\n

Bullish (BLSH)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Neutral rating and raises its price target to $28.00 from $25.00.<\/p>\n

Camden National (CAC)<\/strong> \u2014 Stephens maintains its Equal Weight rating and raises its price target to $59.00 from $58.00.<\/p>\n

Camden Property Trust (CPT)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and lowers its price target to $107.00 from $118.00.<\/p>\n

Camping World (CWH)<\/strong> \u2014 Truist Financial maintains its Buy rating and lowers its price target to $7.00 from $10.00.<\/p>\n

Canaan (CAN)<\/strong> \u2014 BTIG Research maintains its Buy rating and lowers its price target to $1.00 from $2.00.<\/p>\n

CareDx (CDNA)<\/strong> \u2014 Piper Sandler initiates coverage with a Overweight rating with a price target of $100.00.<\/p>\n

Carlsmed (CARL)<\/strong> \u2014 BTIG Research maintains its Buy rating and raises its price target to $26.00 from $24.00.<\/p>\n

Carlsmed (CARL)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating and raises its price target to $22.00 from $17.00.<\/p>\n

Carlsmed (CARL)<\/strong> \u2014 Truist Financial maintains its Buy rating and raises its price target to $23.00 from $20.00.<\/p>\n

Casella Waste Systems (CWST)<\/strong> \u2014 Barclays maintains its Overweight rating and raises its price target to $109.00 from $104.00.<\/p>\n

Centrus Energy (LEU)<\/strong> \u2014 Jefferies Financial Group maintains its Hold rating.<\/p>\n

Cigna Group (CI)<\/strong> \u2014 Sanford C. Bernstein maintains its Outperform rating and raises its price target to $390.00 from $387.00.<\/p>\n

Cigna Group (CI)<\/strong> \u2014 Wells Fargo & Company sets a price target of $390.00.<\/p>\n

Citizens (CIZN)<\/strong> \u2014 Jefferies Financial Group sets a price target of $32.00.<\/p>\n

Citizens (CIZN)<\/strong> \u2014 UBS Group maintains its Market Outperform rating.<\/p>\n

Cognex (CGNX)<\/strong> \u2014 Jefferies Financial Group initiates coverage with a Buy rating with a price target of $64.00.<\/p>\n

CommVault Systems (CVLT)<\/strong> \u2014 Mizuho sets a price target of $200.00.<\/p>\n

CommVault Systems (CVLT)<\/strong> \u2014 UBS Group maintains its Outperform rating.<\/p>\n

Concentra Group Holdings Parent (CON)<\/strong> \u2014 Royal Bank Of Canada maintains its Outperform rating and raises its price target to $49.00 from $42.00.<\/p>\n

ConocoPhillips (COP)<\/strong> \u2014 Freedom Broker downgrades from Buy to Hold and raises its price target to $138.00 from $122.00.<\/p>\n

ConocoPhillips (COP)<\/strong> \u2014 The Goldman Sachs Group maintains its Buy rating.<\/p>\n

Corbus Pharmaceuticals (CRBP)<\/strong> \u2014 Oppenheimer maintains its Outperform rating.<\/p>\n

Core & Main (CNM)<\/strong> \u2014 Barclays maintains its Overweight rating and lowers its price target to $60.00 from $61.00.<\/p>\n

Core & Main (CNM)<\/strong> \u2014 Robert W. Baird maintains its Outperform rating and lowers its price target to $54.00 from $57.00.<\/p>\n

CoreWeave (CRWV)<\/strong> \u2014 Cantor Fitzgerald maintains its Overweight rating and lowers its price target to $100.00 from $176.00.<\/p>\n

CoreWeave (CRWV)<\/strong> \u2014 Citigroup maintains its Buy rating and raises its price target to $149.00 from $128.00.<\/p>\n

CoreWeave (CRWV)<\/strong> \u2014 DA Davidson maintains its Neutral rating and lowers its price target to $45.00 from $100.00.<\/p>\n

CoreWeave (CRWV)<\/strong> \u2014 Mizuho sets a price target of $68.00.<\/p>\n

CoreWeave (CRWV)<\/strong> \u2014 Needham & Company LLC maintains its Hold rating.<\/p>\n

CoreWeave (CRWV)<\/strong> \u2014 Stifel Nicolaus maintains its Hold rating and lowers its price target to $60.00 from $120.00.<\/p>\n

CoreWeave (CRWV)<\/strong> \u2014 Truist Financial maintains its Buy rating and lowers its price target to $115.00 from $165.00.<\/p>\n

Corning (GLW)<\/strong> \u2014 Jefferies Financial Group initiates coverage with a Buy rating with a price target of $134.00.<\/p>\n

Costco Wholesale (COST)<\/strong> \u2014 Sanford C. Bernstein maintains its Outperform rating and raises its price target to $1,155.00 from $1,143.00.<\/p>\n

Crescent Capital BDC (CCAP)<\/strong> \u2014 LADENBURG THALM\/SH SH downgrades from Buy to Neutral with a price target of $10.00.<\/p>\n

Crescent Capital BDC (CCAP)<\/strong> \u2014 Wells Fargo & Company maintains its Equal Weight rating and lowers its price target to $10.00 from $11.00.<\/p>\n

Cullinan Therapeutics (CGEM)<\/strong> \u2014 Wedbush maintains its Outperform rating and raises its price target to $44.00 from $42.00.<\/p>\n

D-Wave Quantum (QBTS)<\/strong> \u2014 Canaccord Genuity Group maintains its Buy rating and lowers its price target to $31.00 from $35.00.<\/p>\n

D-Wave Quantum (QBTS)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating and lowers its price target to $20.00 from $40.00.<\/p>\n

D-Wave Quantum (QBTS)<\/strong> \u2014 Rosenblatt Securities maintains its Buy rating and lowers its price target to $30.00 from $43.00.<\/p>\n

D-Wave Quantum (QBTS)<\/strong> \u2014 Stifel Nicolaus maintains its Buy rating and lowers its price target to $23.00 from $35.00.<\/p>\n

Delek US (DK)<\/strong> \u2014 Freedom Broker upgrades from Hold to Buy and raises its price target to $88.00 from $86.00.<\/p>\n

Doximity (DOCS)<\/strong> \u2014 Barclays maintains its Equal Weight rating and raises its price target to $30.00 from $27.00.<\/p>\n

Draganfly (DPRO)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating and lowers its price target to $6.00 from $8.00.<\/p>\n

Eaton (ETN)<\/strong> \u2014 Jefferies Financial Group initiates coverage with a Neutral rating with a price target of $395.00.<\/p>\n

Eaton (ETN)<\/strong> \u2014 JPMorgan Chase & Co. changes its rating from Overweight to Neutral with a price target of $395.00.<\/p>\n

Ecovyst (ECVT)<\/strong> \u2014 Citigroup maintains its Neutral rating and lowers its price target to $12.00 from $13.00.<\/p>\n

Edwards Lifesciences (EW)<\/strong> \u2014 TD Cowen maintains its Buy rating and raises its price target to $121.00 from $117.00.<\/p>\n

Elmet Group (ELMT)<\/strong> \u2014 Canaccord Genuity Group maintains its Buy rating and raises its price target to $28.00 from $26.00.<\/p>\n

Energizer (ENR)<\/strong> \u2014 UBS Group maintains its Neutral rating.<\/p>\n

Energy Vault (NRGV)<\/strong> \u2014 Cantor Fitzgerald maintains its Overweight rating and raises its price target to $12.00 from $7.00.<\/p>\n

Energy Vault (NRGV)<\/strong> \u2014 Citigroup maintains its Buy rating and raises its price target to $5.00 from $4.75.<\/p>\n

EPAM Systems (EPAM)<\/strong> \u2014 Citigroup maintains its Neutral rating and raises its price target to $172.00 from $140.00.<\/p>\n

EquipmentShare.com (EQPT)<\/strong> \u2014 Wells Fargo & Company maintains its Overweight rating and lowers its price target to $17.00 from $19.00.<\/p>\n

Ermenegildo Zegna (ZGN)<\/strong> \u2014 TD Cowen maintains its Buy rating and raises its price target to $17.00 from $16.00.<\/p>\n

Essential Utilities (WTRG)<\/strong> \u2014 Argus maintains its Buy rating and raises its price target to $50.00 from $45.00.<\/p>\n

Essex Property Trust (ESS)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and lowers its price target to $285.00 from $302.00.<\/p>\n

eToro Group (ETOR)<\/strong> \u2014 Canaccord Genuity Group maintains its Buy rating and lowers its price target to $40.00 from $47.00.<\/p>\n

eToro Group (ETOR)<\/strong> \u2014 Mizuho sets a price target of $33.00.<\/p>\n

eToro Group (ETOR)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating and lowers its price target to $45.00 from $54.00.<\/p>\n

eToro Group (ETOR)<\/strong> \u2014 TD Cowen maintains its Buy rating and lowers its price target to $26.00 from $33.00.<\/p>\n

Eupraxia Pharmaceuticals (EPRX)<\/strong> \u2014 HC Wainwright maintains its Buy rating and raises its price target to $16.00 from $11.00.<\/p>\n

Exagen (XGN)<\/strong> \u2014 BTIG Research maintains its Buy rating with a price target of $9.00.<\/p>\n

Exagen (XGN)<\/strong> \u2014 Canaccord Genuity Group maintains its Buy rating and lowers its price target to $9.00 from $11.00.<\/p>\n

Expedia Group (EXPE)<\/strong> \u2014 Argus maintains its Buy rating and lowers its price target to $300.00 from $360.00.<\/p>\n

FactSet Research Systems (FDS)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and raises its price target to $321.00 from $300.00.<\/p>\n

FactSet Research Systems (FDS)<\/strong> \u2014 Stifel Nicolaus maintains its Hold rating and raises its price target to $325.00 from $292.00.<\/p>\n

Fidelity National Information Services (FIS)<\/strong> \u2014 Sanford C. Bernstein maintains its Market Perform rating and lowers its price target to $31.00 from $48.00.<\/p>\n

Firefly Aerospace (FLY)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and raises its price target to $54.00 from $40.00.<\/p>\n

Firefly Aerospace (FLY)<\/strong> \u2014 Barclays maintains its Equal Weight rating and raises its price target to $35.00 from $34.00.<\/p>\n

Fiserv (FISV)<\/strong> \u2014 Citigroup maintains its Neutral rating and raises its price target to $67.00 from $62.00.<\/p>\n

Fiserv (FISV)<\/strong> \u2014 Sanford C. Bernstein maintains its Market Perform rating and raises its price target to $70.00 from $60.00.<\/p>\n

Five Below (FIVE)<\/strong> \u2014 Sanford C. Bernstein maintains its Outperform rating and raises its price target to $279.00 from $272.00.<\/p>\n

Flywire (FLYW)<\/strong> \u2014 Truist Financial maintains its Hold rating and raises its price target to $23.00 from $19.00.<\/p>\n

Forgent Power Solutions (FPS)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Overweight rating and lowers its price target to $35.00 from $49.00.<\/p>\n

FormFactor (FORM)<\/strong> \u2014 Jefferies Financial Group changes its rating from Hold to Buy with a price target of $102.00.<\/p>\n

Fortrea (FTRE)<\/strong> \u2014 Mizuho downgrades from Neutral to Underperform and raises its price target to $19.00 from $16.00.<\/p>\n

Freenome (FRNM)<\/strong> \u2014 BTIG Research maintains its Buy rating.<\/p>\n

FS KKR Capital (FSK)<\/strong> \u2014 B. Riley Financial maintains its Neutral rating and raises its price target to $12.00 from $11.00.<\/p>\n

GE HealthCare Technologies (GEHC)<\/strong> \u2014 Argus maintains its Buy rating and raises its price target to $110.00 from $85.00.<\/p>\n

GE Vernova (GEV)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Overweight rating and lowers its price target to $1,000.00 from $1,035.00.<\/p>\n

Gen Digital (GEN)<\/strong> \u2014 Argus maintains its Buy rating and raises its price target to $35.00 from $32.00.<\/p>\n

Gevo (GEVO)<\/strong> \u2014 HC Wainwright maintains its Buy rating.<\/p>\n

GFL Environmental (GFL)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Underweight rating and lowers its price target to $40.00 from $42.00.<\/p>\n

Gilat Satellite Networks (GILT)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating and lowers its price target to $11.00 from $20.00.<\/p>\n

Gladstone Investment (GAIN)<\/strong> \u2014 LADENBURG THALM\/SH SH upgrades from Neutral to Buy with a price target of $17.00.<\/p>\n

Global Medical REIT (XRN)<\/strong> \u2014 Citizens Jmp maintains its Market Outperform rating and lowers its price target to $35.00 from $42.00.<\/p>\n

Global Payments (GPN)<\/strong> \u2014 Sanford C. Bernstein maintains its Market Perform rating and raises its price target to $100.00 from $86.00.<\/p>\n

Globant (GLOB)<\/strong> \u2014 Guggenheim downgrades from Buy to Neutral.<\/p>\n

GMR Solutions (GMRS)<\/strong> \u2014 Citigroup maintains its Buy rating and lowers its price target to $15.00 from $17.00.<\/p>\n

Gossamer Bio (GOSS)<\/strong> \u2014 Wedbush maintains its Neutral rating with a price target of $32.00.<\/p>\n

Grocery Outlet (GO)<\/strong> \u2014 Guggenheim maintains its Neutral rating.<\/p>\n

Grocery Outlet (GO)<\/strong> \u2014 TD Cowen maintains its Hold rating and raises its price target to $14.00 from $12.00.<\/p>\n

Grocery Outlet (GO)<\/strong> \u2014 Telsey Advisory Group sets a price target of $14.00.<\/p>\n

Grocery Outlet (GO)<\/strong> \u2014 Wells Fargo & Company maintains its Equal Weight rating and raises its price target to $13.00 from $11.00.<\/p>\n

Guidewire Software (GWRE)<\/strong> \u2014 Jefferies Financial Group initiates coverage with a Hold rating with a price target of $175.00.<\/p>\n

Halozyme Therapeutics (HALO)<\/strong> \u2014 Morgan Stanley downgrades from Overweight to Equal Weight and raises its price target to $109.00 from $105.00.<\/p>\n

Harrow (HROW)<\/strong> \u2014 BTIG Research maintains its Buy rating with a price target of $63.00.<\/p>\n

Herbalife (HLF)<\/strong> \u2014 Argus maintains its Buy rating and raises its price target to $20.00 from $15.00.<\/p>\n

Hilltop (HTH)<\/strong> \u2014 Piper Sandler maintains its Neutral rating and lowers its price target to $36.00 from $42.00.<\/p>\n

HIVE Digital Technologies (HIVE)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and lowers its price target to $5.00 from $8.00.<\/p>\n

HIVE Digital Technologies (HIVE)<\/strong> \u2014 HC Wainwright maintains its Buy rating and lowers its price target to $5.00 from $6.00.<\/p>\n

Horizon Quantum Computing Pte. (HQ)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating and lowers its price target to $19.00 from $20.00.<\/p>\n

Hubbell (HUBB)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Neutral rating and lowers its price target to $470.00 from $486.00.<\/p>\n

Humacyte (HUMA)<\/strong> \u2014 Barclays maintains its Equal Weight rating and raises its price target to $0.60 from $0.50.<\/p>\n

Humana (HUM)<\/strong> \u2014 TD Cowen maintains its Hold rating and raises its price target to $430.00 from $370.00.<\/p>\n

IMAX (IMAX)<\/strong> \u2014 BTIG Research maintains its Neutral rating.<\/p>\n

Inovio Pharmaceuticals (INO)<\/strong> \u2014 Piper Sandler maintains its Overweight rating and lowers its price target to $6.00 from $8.00.<\/p>\n

iRhythm Technologies (IRTC)<\/strong> \u2014 Stephens maintains its Overweight rating and lowers its price target to $120.00 from $160.00.<\/p>\n

Janus International Group (JBI)<\/strong> \u2014 KeyCorp maintains its Overweight rating and lowers its price target to $7.00 from $9.00.<\/p>\n

JBT Marel (JBTM)<\/strong> \u2014 Jefferies Financial Group initiates coverage with a Hold rating with a price target of $142.00.<\/p>\n

Jerash Holdings (US) (JRSH)<\/strong> \u2014 DA Davidson maintains its Buy rating and raises its price target to $10.00 from $6.00.<\/p>\n

Johnson Controls International (JCI)<\/strong> \u2014 JPMorgan Chase & Co. resumes coverage with a Neutral rating with a price target of $160.00.<\/p>\n

KKR & Co. Inc. (KKR)<\/strong> \u2014 Piper Sandler maintains its Overweight rating and raises its price target to $125.00 from $121.00.<\/p>\n

Kopin (KOPN)<\/strong> \u2014 Oppenheimer maintains its Outperform rating.<\/p>\n

KORU Medical Systems (KRMD)<\/strong> \u2014 Piper Sandler maintains its Neutral rating and lowers its price target to $4.50 from $5.00.<\/p>\n

Landstar System (LSTR)<\/strong> \u2014 Morgan Stanley maintains its Underweight rating and lowers its price target to $130.00 from $145.00.<\/p>\n

Lantronix (LTRX)<\/strong> \u2014 Canaccord Genuity Group maintains its Buy rating and lowers its price target to $10.50 from $11.00.<\/p>\n

Legacy Housing (LEGH)<\/strong> \u2014 B. Riley Financial maintains its Neutral rating and raises its price target to $27.00 from $24.00.<\/p>\n

Legend Biotech (LEGN)<\/strong> \u2014 Barclays maintains its Overweight rating and lowers its price target to $61.00 from $68.00.<\/p>\n

Legend Biotech (LEGN)<\/strong> \u2014 Morgan Stanley maintains its Overweight rating and lowers its price target to $43.00 from $49.00.<\/p>\n

Legend Biotech (LEGN)<\/strong> \u2014 Oppenheimer maintains its Market Perform rating and lowers its price target to $25.00 from $40.00.<\/p>\n

Legend Biotech (LEGN)<\/strong> \u2014 Royal Bank Of Canada maintains its Outperform rating and lowers its price target to $50.00 from $56.00.<\/p>\n

Leonardo DRS (DRS)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Neutral rating and lowers its price target to $48.00 from $53.00.<\/p>\n

Life360 (LIF)<\/strong> \u2014 Bank of America downgrades from Buy to Neutral and lowers its price target to $45.00 from $60.00.<\/p>\n

Life360 (LIF)<\/strong> \u2014 Citigroup maintains its Buy rating and lowers its price target to $56.60 from $60.00.<\/p>\n

Life360 (LIF)<\/strong> \u2014 UBS Group sets a price target of $45.00.<\/p>\n

Lifeway Foods (LWAY)<\/strong> \u2014 BTIG Research maintains its Buy rating with a price target of $30.00.<\/p>\n

Ligand Pharmaceuticals (LGND)<\/strong> \u2014 Barclays maintains its Overweight rating and raises its price target to $350.00 from $345.00.<\/p>\n

Lineage (LINE)<\/strong> \u2014 Robert W. Baird maintains its Neutral rating and lowers its price target to $40.00 from $43.00.<\/p>\n

Liquidia (LQDA)<\/strong> \u2014 Bank of America maintains its Neutral rating with a price target of $54.00.<\/p>\n

Liquidia (LQDA)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating and raises its price target to $66.00 from $58.00.<\/p>\n

Liquidia (LQDA)<\/strong> \u2014 Raymond James Financial upgrades from Outperform to Strong-Buy and raises its price target to $77.00 from $53.00.<\/p>\n

Liquidia (LQDA)<\/strong> \u2014 Wells Fargo & Company maintains its Equal Weight rating and raises its price target to $40.00 from $33.00.<\/p>\n

Littelfuse (LFUS)<\/strong> \u2014 Jefferies Financial Group changes its rating from Hold to Buy with a price target of $471.00.<\/p>\n

Lucid Group (LCID)<\/strong> \u2014 Citigroup maintains its Buy rating and lowers its price target to $9.00 from $11.00.<\/p>\n

Lumexa Imaging (LMRI)<\/strong> \u2014 Raymond James Financial maintains its Strong-Buy rating with a price target of $19.00.<\/p>\n

Lumexa Imaging (LMRI)<\/strong> \u2014 UBS Group maintains its Strong-Buy rating.<\/p>\n

LuxExperience B.V. (LUXE)<\/strong> \u2014 TD Cowen maintains its Buy rating and raises its price target to $12.00 from $11.00.<\/p>\n

MARA (MARA)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Underweight rating and lowers its price target to $9.00 from $11.00.<\/p>\n

Martin Marietta Materials (MLM)<\/strong> \u2014 Stifel Nicolaus maintains its Buy rating and raises its price target to $653.00 from $629.00.<\/p>\n

Mastercard (MA)<\/strong> \u2014 Sanford C. Bernstein maintains its Outperform rating and raises its price target to $764.00 from $730.00.<\/p>\n

Maze Therapeutics (MAZE)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Overweight rating and lowers its price target to $51.00 from $53.00.<\/p>\n

Medallion Financial (MFIN)<\/strong> \u2014 Piper Sandler maintains its Neutral rating and lowers its price target to $10.00 from $12.00.<\/p>\n

Mercury Systems (MRCY)<\/strong> \u2014 JPMorgan Chase & Co. upgrades from Neutral to Overweight and lowers its price target to $102.00 from $110.00.<\/p>\n

Mercury Systems (MRCY)<\/strong> \u2014 Piper Sandler maintains its Overweight rating with a price target of $107.00.<\/p>\n

Mid-America Apartment Communities (MAA)<\/strong> \u2014 Morgan Stanley downgrades from Overweight to Equal Weight and lowers its price target to $134.00 from $147.00.<\/p>\n

Mirum Pharmaceuticals (MIRM)<\/strong> \u2014 Citigroup maintains its Buy rating and raises its price target to $194.00 from $184.00.<\/p>\n

Morgan Stanley Direct Lending Fund (MSDL)<\/strong> \u2014 Royal Bank Of Canada maintains its Sector Perform rating and lowers its price target to $14.00 from $16.00.<\/p>\n

Mosaic (MOS)<\/strong> \u2014 Freedom Broker downgrades from Hold to Sell and raises its price target to $18.00 from $17.00.<\/p>\n

Mplx (MPLX)<\/strong> \u2014 Barclays maintains its Overweight rating and lowers its price target to $61.00 from $63.00.<\/p>\n

MSC Income Fund (MSIF)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and raises its price target to $14.00 from $13.00.<\/p>\n

National Fuel Gas (NFG)<\/strong> \u2014 KeyCorp maintains its Overweight rating and lowers its price target to $91.00 from $95.00.<\/p>\n

NewAmsterdam Pharma (NAMS)<\/strong> \u2014 Cantor Fitzgerald maintains its Overweight rating and raises its price target to $61.00 from $52.00.<\/p>\n

NexGen Energy (NXE)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Overweight rating and lowers its price target to $12.00 from $14.00.<\/p>\n

NIKE (NKE)<\/strong> \u2014 KeyCorp maintains its Sector Weight rating.<\/p>\n

Northern Oil and Gas (NOG)<\/strong> \u2014 Citigroup maintains its Buy rating and lowers its price target to $30.00 from $32.00.<\/p>\n

nVent Electric (NVT)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Overweight rating and lowers its price target to $155.00 from $167.00.<\/p>\n

NVIDIA (NVDA)<\/strong> \u2014 Evercore downgrades from Outperform to Positive.<\/p>\n

NVIDIA (NVDA)<\/strong> \u2014 Jefferies Financial Group changes its rating from Buy to Hold.<\/p>\n

NVIDIA (NVDA)<\/strong> \u2014 Morgan Stanley maintains its Overweight rating with a price target of $300.00.<\/p>\n

NVIDIA (NVDA)<\/strong> \u2014 Raymond James Financial upgrades from Outperform to Strong-Buy.<\/p>\n

NVIDIA (NVDA)<\/strong> \u2014 Robert W. Baird downgrades from Outperform to Neutral and lowers its price target to $200.00 from $500.00.<\/p>\n

Occidental Petroleum (OXY)<\/strong> \u2014 Wells Fargo & Company maintains its Overweight rating and lowers its price target to $76.00 from $82.00.<\/p>\n

OceanFirst Financial (OCFC)<\/strong> \u2014 Piper Sandler maintains its Neutral rating and raises its price target to $19.50 from $18.00.<\/p>\n

ODDITY Tech (ODD)<\/strong> \u2014 The Goldman Sachs Group maintains its Sell rating.<\/p>\n

Omega Healthcare Investors (OHI)<\/strong> \u2014 Citigroup maintains its Market Outperform rating.<\/p>\n

ON (ONON)<\/strong> \u2014 Barclays maintains its Overweight rating and lowers its price target to $42.00 from $44.00.<\/p>\n

ON (ONON)<\/strong> \u2014 HC Wainwright sets a price target of $43.00.<\/p>\n

ON (ONON)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Overweight rating and raises its price target to $46.00 from $44.00.<\/p>\n

ON (ONON)<\/strong> \u2014 KeyCorp maintains its Overweight rating and raises its price target to $42.00 from $37.00.<\/p>\n

ON (ONON)<\/strong> \u2014 Morgan Stanley maintains its Overweight rating and raises its price target to $43.00 from $39.00.<\/p>\n

Opus Genetics (IRD)<\/strong> \u2014 HC Wainwright maintains its Buy rating and raises its price target to $14.00 from $8.00.<\/p>\n

Opus Genetics (IRD)<\/strong> \u2014 Royal Bank Of Canada maintains its Outperform rating and raises its price target to $11.00 from $9.00.<\/p>\n

P3 Health Partners (PIII)<\/strong> \u2014 TD Cowen maintains its Hold rating and lowers its price target to $4.00 from $13.00.<\/p>\n

Palisade Bio (PALI)<\/strong> \u2014 HC Wainwright maintains its Buy rating with a price target of $5.00.<\/p>\n

Palladyne AI (PDYN)<\/strong> \u2014 Jefferies Financial Group maintains its Hold rating with a price target of $5.50.<\/p>\n

Palo Alto Networks (PANW)<\/strong> \u2014 Evercore maintains its Outperform rating.<\/p>\n

PayPal (PYPL)<\/strong> \u2014 Sanford C. Bernstein maintains its Market Perform rating and raises its price target to $60.00 from $55.00.<\/p>\n

Paysign (PAYS)<\/strong> \u2014 DA Davidson maintains its Buy rating and lowers its price target to $14.00 from $15.00.<\/p>\n

Paysign (PAYS)<\/strong> \u2014 Maxim Group downgrades from Buy to Hold.<\/p>\n

Pediatrix Medical Group (MD)<\/strong> \u2014 Mizuho downgrades from Neutral to Underperform with a price target of $28.00.<\/p>\n

PepGen (PEPG)<\/strong> \u2014 Wedbush maintains its Outperform rating and raises its price target to $10.00 from $4.00.<\/p>\n

Phreesia (PHR)<\/strong> \u2014 JPMorgan Chase & Co. downgrades from Neutral to Underweight with a price target of $13.00.<\/p>\n

Plains All American Pipeline (PAA)<\/strong> \u2014 Barclays maintains its Underweight rating and raises its price target to $25.00 from $24.00.<\/p>\n

Plains All American Pipeline (PAA)<\/strong> \u2014 Wells Fargo & Company maintains its Equal Weight rating and raises its price target to $25.00 from $23.00.<\/p>\n

Plains GP (PAGP)<\/strong> \u2014 Barclays maintains its Underweight rating and raises its price target to $25.00 from $24.00.<\/p>\n

Plains GP (PAGP)<\/strong> \u2014 Wells Fargo & Company maintains its Equal Weight rating and raises its price target to $25.00 from $23.00.<\/p>\n

Plug Power (PLUG)<\/strong> \u2014 Susquehanna maintains its Neutral rating and lowers its price target to $1.50 from $1.75.<\/p>\n

Praxis Precision Medicines (PRAX)<\/strong> \u2014 HC Wainwright maintains its Buy rating.<\/p>\n

QuickLogic (QUIK)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating and lowers its price target to $12.00 from $20.00.<\/p>\n

QumulusAI (QMLS)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and lowers its price target to $9.00 from $11.00.<\/p>\n

QumulusAI (QMLS)<\/strong> \u2014 Chardan Capital maintains its Buy rating with a price target of $13.00.<\/p>\n

RB Global (RBA)<\/strong> \u2014 Barclays maintains its Overweight rating and raises its price target to $112.00 from $110.00.<\/p>\n

Regal Rexnord (RRX)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Overweight rating and lowers its price target to $195.00 from $196.00.<\/p>\n

Republic Services (RSG)<\/strong> \u2014 JPMorgan Chase & Co. upgrades from Neutral to Overweight and raises its price target to $295.00 from $265.00.<\/p>\n

Resideo Technologies (REZI)<\/strong> \u2014 Oppenheimer maintains its Outperform rating and lowers its price target to $25.00 from $27.00.<\/p>\n

RideNow Group (RDNW)<\/strong> \u2014 Robert W. Baird maintains its Neutral rating and lowers its price target to $5.50 from $9.00.<\/p>\n

Rigetti Computing (RGTI)<\/strong> \u2014 Jefferies Financial Group maintains its Hold rating with a price target of $12.00.<\/p>\n

Rigetti Computing (RGTI)<\/strong> \u2014 Mizuho sets a price target of $17.00.<\/p>\n

Rigetti Computing (RGTI)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating and lowers its price target to $15.00 from $31.00.<\/p>\n

Riot Platforms (RIOT)<\/strong> \u2014 Keefe Bruyette downgrades from Outperform to Market Perform with a price target of $23.<\/p>\n

Rocket Lab (RKLB)<\/strong> \u2014 Morgan Stanley maintains its Overweight rating and lowers its price target to $103.00 from $105.00.<\/p>\n

Rocket Lab (RKLB)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating and lowers its price target to $100.00 from $120.00.<\/p>\n

Sally Beauty (SBH)<\/strong> \u2014 Canaccord Genuity Group maintains its Buy rating and raises its price target to $25.00 from $20.00.<\/p>\n

Sally Beauty (SBH)<\/strong> \u2014 Jefferies Financial Group maintains its Hold rating with a price target of $21.00.<\/p>\n

Sally Beauty (SBH)<\/strong> \u2014 Morgan Stanley maintains its Underweight rating and raises its price target to $19.00 from $13.00.<\/p>\n

Satellogic (SATL)<\/strong> \u2014 Cantor Fitzgerald maintains its Overweight rating and lowers its price target to $7.00 from $9.00.<\/p>\n

Savers Value Village (SVV)<\/strong> \u2014 BTIG Research maintains its Buy rating with a price target of $15.00.<\/p>\n

SEA (SE)<\/strong> \u2014 Bank of America maintains its Buy rating with a price target of $110.00.<\/p>\n

SEA (SE)<\/strong> \u2014 TD Cowen maintains its Hold rating and lowers its price target to $90.00 from $100.00.<\/p>\n

Select Water Solutions (WTTR)<\/strong> \u2014 Citigroup maintains its Buy rating and lowers its price target to $23.00 from $24.00.<\/p>\n

Sensata Technologies (ST)<\/strong> \u2014 Jefferies Financial Group initiates coverage with a Hold rating with a price target of $40.00.<\/p>\n

ServiceTitan (TTAN)<\/strong> \u2014 Jefferies Financial Group initiates coverage with a Hold rating with a price target of $86.00.<\/p>\n

Solaris Energy Infrastructure (SEI)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating and raises its price target to $126.00 from $104.00.<\/p>\n

Sonida Senior Living (SNDA)<\/strong> \u2014 Royal Bank Of Canada maintains its Outperform rating and lowers its price target to $43.00 from $48.00.<\/p>\n

Spire Global (SPIR)<\/strong> \u2014 Stifel Nicolaus maintains its Buy rating and lowers its price target to $20.00 from $24.00.<\/p>\n

SPX Technologies (SPXC)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Overweight rating and lowers its price target to $190.00 from $225.00.<\/p>\n

Starwood Property Trust (STWD)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Overweight rating and lowers its price target to $15.50 from $16.00.<\/p>\n

Stellus Capital Investment (SCM)<\/strong> \u2014 Loop Capital maintains its Neutral rating.<\/p>\n

Stellus Capital Investment (SCM)<\/strong> \u2014 Noble Financial maintains its Neutral rating.<\/p>\n

STUB (STUB)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Neutral rating and lowers its price target to $8.00 from $11.00.<\/p>\n

Suja Life (SUJA)<\/strong> \u2014 Jefferies Financial Group maintains its Buy rating.<\/p>\n

Suja Life (SUJA)<\/strong> \u2014 The Goldman Sachs Group downgrades from Buy to Neutral with a price target of $12.00.<\/p>\n

Surgery Partners (SGRY)<\/strong> \u2014 Mizuho downgrades from Outperform to Neutral and raises its price target to $25.00 from $19.00.<\/p>\n

Surgery Partners (SGRY)<\/strong> \u2014 TD Cowen maintains its Hold rating and raises its price target to $25.00 from $23.50.<\/p>\n

Surrozen (SRZN)<\/strong> \u2014 Guggenheim maintains its Buy rating with a price target of $80.00.<\/p>\n

Symbotic (SYM)<\/strong> \u2014 Jefferies Financial Group changes its rating from Buy to Hold with a price target of $35.00.<\/p>\n

Teradyne (TER)<\/strong> \u2014 Jefferies Financial Group initiates coverage with a Buy rating with a price target of $284.00.<\/p>\n

Terrestrial Energy (IMSR)<\/strong> \u2014 Northland Securities downgrades from Outperform to Market Perform with a price target of $3.25.<\/p>\n

The Hartford Insurance Group (HIG)<\/strong> \u2014 Wells Fargo & Company downgrades from Overweight to Equal Weight and lowers its price target to $139.00 from $158.00.<\/p>\n

Thryv (THRY)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating.<\/p>\n

TIM (TIMB)<\/strong> \u2014 Barclays maintains its Equal Weight rating and lowers its price target to $20.00 from $22.00.<\/p>\n

Toast (TOST)<\/strong> \u2014 Sanford C. Bernstein downgrades from Outperform to Market Perform and lowers its price target to $38.00 from $45.00.<\/p>\n

Trade Desk (TTD)<\/strong> \u2014 Cantor Fitzgerald maintains its Neutral rating and raises its price target to $15.00 from $14.00.<\/p>\n

Trade Desk (TTD)<\/strong> \u2014 Piper Sandler maintains its Neutral rating and raises its price target to $16.00 from $14.00.<\/p>\n

Trade Desk (TTD)<\/strong> \u2014 Wells Fargo & Company maintains its Equal Weight rating and raises its price target to $15.00 from $12.00.<\/p>\n

Trane Technologies (TT)<\/strong> \u2014 JPMorgan Chase & Co. maintains its Overweight rating and lowers its price target to $480.00 from $550.00.<\/p>\n

Transdigm Group (TDG)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and raises its price target to $1,405.00 from $1,300.00.<\/p>\n

Transdigm Group (TDG)<\/strong> \u2014 Royal Bank Of Canada maintains its Sector Perform rating and raises its price target to $1,300.00 from $1,200.00.<\/p>\n

Transdigm Group (TDG)<\/strong> \u2014 TD Cowen maintains its Buy rating and raises its price target to $1,350.00 from $1,300.00.<\/p>\n

TriSalus Life Sciences (TLSI)<\/strong> \u2014 HC Wainwright maintains its Buy rating and lowers its price target to $10.00 from $12.00.<\/p>\n

Tyra Biosciences (TYRA)<\/strong> \u2014 HC Wainwright maintains its Buy rating and lowers its price target to $27.00 from $29.00.<\/p>\n

Tyra Biosciences (TYRA)<\/strong> \u2014 Wedbush maintains its Outperform rating and raises its price target to $57.00 from $53.00.<\/p>\n

Unilever (UL)<\/strong> \u2014 Deutsche Bank upgrades from Hold to Buy.<\/p>\n

Unilever (UL)<\/strong> \u2014 Deutsche Bank Aktiengesellschaft upgrades from Hold to Buy.<\/p>\n

United Dominion Realty Trust (UDR)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and lowers its price target to $41.00 from $42.00.<\/p>\n

Universal Health Services (UHS)<\/strong> \u2014 Royal Bank Of Canada maintains its Sector Perform rating and raises its price target to $207.00 from $183.00.<\/p>\n

Upstream Bio (UPB)<\/strong> \u2014 HC Wainwright maintains its Buy rating with a price target of $18.00.<\/p>\n

USA Rare Earth (USAR)<\/strong> \u2014 Jefferies Financial Group maintains its Buy rating.<\/p>\n

Veeva Systems (VEEV)<\/strong> \u2014 Wells Fargo & Company maintains its Overweight rating and raises its price target to $400.00 from $330.00.<\/p>\n

Veracyte (VCYT)<\/strong> \u2014 Stephens maintains its Overweight rating and lowers its price target to $40.00 from $55.00.<\/p>\n

Vertiv (VRT)<\/strong> \u2014 JPMorgan Chase & Co. resumes coverage with a Neutral rating with a price target of $240.00.<\/p>\n

Visa (V)<\/strong> \u2014 Sanford C. Bernstein maintains its Outperform rating and raises its price target to $486.00 from $475.00.<\/p>\n

Walmart (WMT)<\/strong> \u2014 Bank of America maintains its Buy rating.<\/p>\n

WESCO International (WCC)<\/strong> \u2014 Barclays maintains its Overweight rating and raises its price target to $450.00 from $437.00.<\/p>\n

WhiteFiber (WYFI)<\/strong> \u2014 BTIG Research maintains its Buy rating and lowers its price target to $30.00 from $50.00.<\/p>\n

WhiteFiber (WYFI)<\/strong> \u2014 HC Wainwright maintains its Buy rating and raises its price target to $36.00 from $34.00.<\/p>\n

WhiteFiber (WYFI)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating and lowers its price target to $37.00 from $41.00.<\/p>\n

Winnebago Industries (WGO)<\/strong> \u2014 Truist Financial maintains its Buy rating and raises its price target to $39.00 from $35.00.<\/p>\n

Wix.com (WIX)<\/strong> \u2014 Cantor Fitzgerald maintains its Overweight rating and lowers its price target to $80.00 from $90.00.<\/p>\n

Wix.com (WIX)<\/strong> \u2014 Citigroup maintains its Neutral rating and lowers its price target to $71.00 from $72.00.<\/p>\n

Wix.com (WIX)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and raises its price target to $73.00 from $65.00.<\/p>\n

Wix.com (WIX)<\/strong> \u2014 Royal Bank Of Canada maintains its Sector Perform rating and lowers its price target to $58.00 from $60.00.<\/p>\n

Wix.com (WIX)<\/strong> \u2014 Wells Fargo & Company maintains its Equal Weight rating and lowers its price target to $63.00 from $64.00.<\/p>\n

Xeris Biopharma (XERS)<\/strong> \u2014 Barclays maintains its Overweight rating and raises its price target to $18.00 from $14.00.<\/p>\n

Zebra Technologies (ZBRA)<\/strong> \u2014 Jefferies Financial Group initiates coverage with a Buy rating with a price target of $382.00.<\/p>\n

Zeta Global (ZETA)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and raises its price target to $33.00 from $25.00.<\/p>\n

Ziff Davis (ZD)<\/strong> \u2014 Citigroup maintains its Neutral rating and lowers its price target to $56.00 from $59.00.<\/p>\n

Zymeworks (ZYME)<\/strong> \u2014 Citigroup maintains its Buy rating and raises its price target to $44.00 from $39.00.<\/p>\n","protected":false},"excerpt":{"rendered":"

Analyst Ratings (USA) American analyst sentiment on November 11th remains mixed and increasingly cautious, with notable downgrades across artificial intelligence, semiconductors, software, financial services…<\/p>\n","protected":false},"author":3,"featured_media":70370,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-77038","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"\nAmerican Analyst Updates: Nov 11th, 2026 | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-11th-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"American Analyst Updates: Nov 11th, 2026\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings (USA) American analyst sentiment on November 11th remains mixed and increasingly cautious, with notable downgrades across artificial intelligence, semiconductors, software, financial services…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-11th-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-11T20:13:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-11T20:40:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2025\/12\/Apple-stock-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1016\" \/>\n\t<meta property=\"og:image:height\" content=\"485\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"24 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-11th-2026\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-11th-2026\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"American Analyst Updates: Nov 11th, 2026\",\"datePublished\":\"2026-11-11T20:13:23+00:00\",\"dateModified\":\"2026-11-11T20:40:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-11th-2026\/\"},\"wordCount\":4968,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News & Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-11th-2026\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-11th-2026\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-11th-2026\/\",\"name\":\"American Analyst Updates: Nov 11th, 2026 | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2026-11-11T20:13:23+00:00\",\"dateModified\":\"2026-11-11T20:40:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-11th-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-11th-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-11th-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"American Analyst Updates: Nov 11th, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"American Analyst Updates: Nov 11th, 2026 | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-11th-2026\/","og_locale":"en_US","og_type":"article","og_title":"American Analyst Updates: Nov 11th, 2026","og_description":"Analyst Ratings (USA) American analyst sentiment on November 11th remains mixed and increasingly cautious, with notable downgrades across artificial intelligence, semiconductors, software, financial services…","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-11th-2026\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2026-11-11T20:13:23+00:00","article_modified_time":"2026-11-11T20:40:09+00:00","og_image":[{"width":1016,"height":485,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2025\/12\/Apple-stock-1.jpg","type":"image\/jpeg"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"24 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-11th-2026\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-11th-2026\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"American Analyst Updates: Nov 11th, 2026","datePublished":"2026-11-11T20:13:23+00:00","dateModified":"2026-11-11T20:40:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-11th-2026\/"},"wordCount":4968,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News & Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-11th-2026\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-11th-2026\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-11th-2026\/","name":"American Analyst Updates: Nov 11th, 2026 | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2026-11-11T20:13:23+00:00","dateModified":"2026-11-11T20:40:09+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-11th-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-11th-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-11th-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"American Analyst Updates: Nov 11th, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/77038","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=77038"}],"version-history":[{"count":3,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/77038\/revisions"}],"predecessor-version":[{"id":77048,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/77038\/revisions\/77048"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/70370"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=77038"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=77038"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=77038"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}